NCT00205842View on ClinicalTrials.gov

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

PHASE3CompletedINTERVENTIONAL

Enrollment

660

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Ileus

Interventions

DRUG

alvimopan

Trial Locations (1)

19341

50 Sites, Exton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY